We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$150M
AUM Growth
+$5.45M
Cap. Flow
+$901K
Cap. Flow %
0.6%
Top 10 Hldgs %
30.59%
Holding
146
New
12
Increased
34
Reduced
70
Closed
6

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.09M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$378K
3
USCI icon
US Commodity Index
USCI
+$370K
4
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$353K
5
CEF icon
Sprott Physical Gold and Silver Trust
CEF
+$332K

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$423K
2
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
+$357K
3
VOD icon
Vodafone
VOD
+$284K
4
GSK icon
GSK
GSK
+$256K
5
KMP
KINDER MORGAN ENER PNTRS L.P.
KMP
+$243K

Sector Composition

Rank Sector Weight
1 Healthcare 23.99%
2 Technology 12.59%
3 Financials 12.07%
4 Industrials 9.43%
5 Consumer Staples 6.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
26
Abbott
ABT
$182B
$1.72M 1.14%
38,125
+100
+0.3% +$4.36K
COP icon
27
ConocoPhillips
COP
$145B
$1.7M 1.13%
24,618
-100
-0.4% -$6.98K
MTB icon
28
M&T Bank
MTB
$35.9B
$1.61M 1.07%
12,807
+315
+3% +$38.7K
XOM icon
29
ExxonMobil
XOM
$637B
$1.6M 1.07%
17,300
+230
+1% +$21.4K
BRK.A icon
30
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.58M 1.06%
7
– –
TEVA icon
31
Teva Pharmaceuticals
TEVA
$40.6B
$1.57M 1.05%
27,280
+215
+0.8% +$12K
NVS icon
32
Novartis
NVS
$297B
$1.57M 1.05%
18,888
-45
-0.2% -$3.73K
EXPD icon
33
Expeditors International
EXPD
$22.1B
$1.56M 1.04%
35,053
-250
-0.7% -$10.7K
GE icon
34
GE Aerospace
GE
$373B
$1.47M 0.98%
12,167
+21
+0.2% +$2.58K
TECH icon
35
Bio-Techne
TECH
$11.2B
$1.39M 0.93%
60,160
-600
-1% -$13.7K
VZ icon
36
Verizon
VZ
$194B
$1.32M 0.88%
28,290
+1,527
+6% +$74.7K
CHRW icon
37
C.H. Robinson
CHRW
$17.7B
$1.32M 0.88%
17,589
-180
-1% -$12.8K
AMGN icon
38
Amgen
AMGN
$207B
$1.3M 0.87%
8,159
+76
+0.9% +$11.8K
BIDU icon
39
Baidu
BIDU
$37.4B
$1.29M 0.86%
5,670
-60
-1% -$13.8K
CHL
40
DELISTED
China Mobile Limited
CHL
$1.18M 0.79%
20,025
+50
+0.3% +$3K
BDX icon
41
Becton Dickinson
BDX
$45.4B
$1.18M 0.79%
8,670
– –
WMT icon
42
Walmart Inc
WMT
$888B
$1.16M 0.77%
40,473
+120
+0.3% +$3.24K
DGX icon
43
Quest Diagnostics
DGX
$25.9B
$1.12M 0.75%
16,697
-185
-1% -$11.7K
NSC icon
44
Norfolk Southern
NSC
$75.4B
$1.08M 0.72%
9,875
– –
CME icon
45
CME Group
CME
$96.7B
$1.03M 0.69%
11,585
-180
-2% -$15.3K
CEF icon
46
Sprott Physical Gold and Silver Trust
CEF
$7.39B
$1.01M 0.67%
86,900
+27,975
+47% +$332K
LLL
47
DELISTED
L3 Technologies, Inc.
LLL
$956K 0.64%
7,573
-1,458
-16% -$174K
EMC
48
DELISTED
EMC CORPORATION
EMC
$894K 0.6%
30,056
-450
-1% -$13.1K
RTX icon
49
RTX Corp
RTX
$290B
$797K 0.53%
11,012
+1,225
+13% +$83.5K
GD icon
50
General Dynamics
GD
$104B
$780K 0.52%
5,665
-30
-0.5% -$4.08K
1
2
3 4 5

Similar funds

VBFP
Valtinson Bruner Financial Planning New Brighton, Minnesota $364M AUM 9.63% 1-Year Est. Return
EW
Evexia Wealth Stevens Point, Wisconsin $364M AUM 29.61% 1-Year Est. Return
RBFC
Roman Butler Fullerton & Co St Louis, Missouri $364M AUM 27.64% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $365M AUM
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return
SWA
Strata Wealth Advisors Dallas, Texas $365M AUM 16.8% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Roberts, Glore & Co's Q4 2014 Portfolio in Review

As of Q4 2014, Roberts, Glore & Co held 146 positions worth $150M, up 3.8% from $144M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Roberts, Glore & Co's Q4 2014 filing shows 12 new, 34 increased, 70 reduced and 6 closed positions. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 1,476 shares worth $390K. The largest sale was Intel, an estimated $423K.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Roberts, Glore & Co's largest Q4 2014 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 1,476 shares worth $390K.
  • Roberts, Glore & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.09M increase.
  • Roberts, Glore & Co's biggest Q4 2014 reduction was Intel, cutting an estimated $423K.
  • Roberts, Glore & Co fully exited GSK in Q4 2014, selling an estimated $256K.
  • Roberts, Glore & Co's ten largest holdings make up 31% of its $150M portfolio in Q4 2014.
  • Roberts, Glore & Co opened 12 new positions and closed 6 in Q4 2014.
  • Roberts, Glore & Co's portfolio value rose 3.8% quarter-over-quarter to $150M.

Based on Roberts, Glore & Co's 13F filing for Q4 2014, filed 9 Feb 2015.